No Data
No Data
Stock Market Today: S&P 500 Sector Leaders and Losers, 4/16/26
Research Alert: CFRA Keeps Buy Rating On Shares Of Abbott Laboratories
Express News | Abbott Exec Says Addition of Exact Sciences to Add About $3 Bln in Incremental Sales in 2026, Accelerate Long-Term Sales Growth – Conf Call
Express News | Abbott Reports First-Quarter 2026 Results; Updates Guidance to Reflect Acquisition of Exact Sciences
Press Release: Abbott Reports First-Quarter 2026 Results; Updates Guidance to Reflect Acquisition of Exact Sciences
EXACT Therapeutics Publishes 2025 Annual Report and Highlights PS101 Pipeline Progress